TGFB1 and pulmonary fibrosis: A combination of TGF-β1 signal pathway inhibitors with P-Rex1 inhibitor would shed light on therapeutic approaches for better pulmonary fibrosis treatment (Lucato et al., 2015; Cash et al., 2020).